Verano Holdings (VRNO) Change in Taxes (2021 - 2026)
Verano Holdings' (VRNO) quarterly Change in Taxes came in at -$812000.0 in Q1 2026, up 95.92% year-on-year from -$414454.4 in Q1 2025, and up 88.98% on a QoQ basis from -$7.4 million in Q4 2025.
Verano Holdings (VRNO) Change in Taxes (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Change in Taxes data on file, last reported at -$812000.0 in Q1 2026.
- On a quarterly basis, Change in Taxes rose 95.92% year-over-year to -$812000.0 in Q1 2026; TTM through Mar 2026 was -$32.7 million, a 85.45% increase from a year earlier, with the FY2025 full-year figure at -$51.8 million, up 73.46% from the prior year.
- Change in Taxes for Q1 2026 stood at -$812000.0, up from -$7.4 million in the prior quarter.
- Over the last five years, Change in Taxes for VRNO reached as high as $60.2 million in Q3 2022 and fell as low as -$231.7 million in Q4 2024.
- Historically, Change in Taxes has averaged -$9.2 million across 5 years, with a median of -$5.0 million in 2023.
- On a YoY basis, Change in Taxes climbed as much as 291.25% in 2024 and fell as far as 9052.75% in 2024.
- Year by year, Change in Taxes stood at $30.4 million in 2022, then tumbled by 108.31% to -$2.5 million in 2023, then plunged by 9052.75% to -$231.7 million in 2024, then surged by 96.82% to -$7.4 million in 2025, then surged by 88.98% to -$812000.0 in 2026.
- Per Business Quant data, the three most recent Change in Taxes figures were -$812000.0 in Q1 2026, -$7.4 million in Q4 2025, and -$17.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 73.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -411.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -463.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 119.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | -812,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -812,000.00 |
| Mar 31, 2026 | -812,000.00 |
| Dec 31, 2025 | -7.37 Mn |
| Dec 31, 2025 | -7.37 Mn |
| Sep 30, 2025 | -16.96 Mn |
| Sep 30, 2025 | -16.96 Mn |
| Jun 30, 2025 | -7.55 Mn |
| Jun 30, 2025 | -7.55 Mn |
| Mar 31, 2025 | -19.90 Mn |
| Mar 31, 2025 | -19.90 Mn |
| Dec 31, 2024 | -231.66 Mn |
| Dec 31, 2024 | -231.66 Mn |
| Sep 30, 2024 | 33.75 Mn |
| Sep 30, 2024 | 33.75 Mn |
| Jun 30, 2024 | -6.83 Mn |
| Jun 30, 2024 | -6.83 Mn |
| Mar 31, 2024 | 9.60 Mn |
| Mar 31, 2024 | 9.60 Mn |
| Dec 31, 2023 | -2.53 Mn |
| Dec 31, 2023 | -2.53 Mn |